Congressional researchers are noting that the Food and Drug Administration (FDA) has missed a legal deadline to publish a list of known cannabinoids as federal hemp laws are set to change later this year in a way that stakeholders argue will upend the existing market. As part of appropriations legislation that President Donald Trump signed…...
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
